Madhu Kollareddy

813 total citations
17 papers, 527 citations indexed

About

Madhu Kollareddy is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Madhu Kollareddy has authored 17 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Madhu Kollareddy's work include Cancer, Hypoxia, and Metabolism (8 papers), Cancer-related Molecular Pathways (8 papers) and Neuroblastoma Research and Treatments (6 papers). Madhu Kollareddy is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Cancer-related Molecular Pathways (8 papers) and Neuroblastoma Research and Treatments (6 papers). Madhu Kollareddy collaborates with scholars based in United Kingdom, United States and Australia. Madhu Kollareddy's co-authors include Marián Hajdúch, Petr Džubák, Daniella Zheleva, Pathik S. Brahmkshatriya, Martin Lepšı́k, Gopalakrishnan Ramakrishnan, Krishna M. Chauhan, Marianna Szemes, Luis A. Martinez and Zunamys I. Carrero and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

In The Last Decade

Madhu Kollareddy

17 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Madhu Kollareddy United Kingdom 10 362 235 224 92 56 17 527
Minglei Bian China 7 513 1.4× 299 1.3× 497 2.2× 92 1.0× 37 0.7× 7 725
Galina Semenova United States 7 418 1.2× 227 1.0× 100 0.4× 91 1.0× 36 0.6× 7 579
Parag P. Patwardhan United States 8 349 1.0× 134 0.6× 88 0.4× 62 0.7× 54 1.0× 16 593
Pei Pei Gan Australia 8 450 1.2× 226 1.0× 320 1.4× 84 0.9× 14 0.3× 9 640
William B. Tu Canada 9 602 1.7× 177 0.8× 97 0.4× 111 1.2× 20 0.4× 14 737
Shankar Varadarajan United Kingdom 16 467 1.3× 131 0.6× 106 0.5× 66 0.7× 20 0.4× 24 619
Rachel E. Gershman United States 3 190 0.5× 171 0.7× 221 1.0× 24 0.3× 51 0.9× 3 332
Sabine Rottmann Germany 8 601 1.7× 204 0.9× 156 0.7× 73 0.8× 19 0.3× 12 750
Michael Grondine United States 8 421 1.2× 265 1.1× 76 0.3× 63 0.7× 15 0.3× 14 544

Countries citing papers authored by Madhu Kollareddy

Since Specialization
Citations

This map shows the geographic impact of Madhu Kollareddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madhu Kollareddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madhu Kollareddy more than expected).

Fields of papers citing papers by Madhu Kollareddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madhu Kollareddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madhu Kollareddy. The network helps show where Madhu Kollareddy may publish in the future.

Co-authorship network of co-authors of Madhu Kollareddy

This figure shows the co-authorship network connecting the top 25 collaborators of Madhu Kollareddy. A scholar is included among the top collaborators of Madhu Kollareddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madhu Kollareddy. Madhu Kollareddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kollareddy, Madhu, Marianna Szemes, Evon Poon, et al.. (2024). Spliceosomal vulnerability of MYCN-amplified neuroblastoma is contingent on PRMT5-mediated regulation of epitranscriptomic and metabolomic pathways. Cancer Letters. 604. 217263–217263. 1 indexed citations
2.
Collard, T J, Caroline J. Bull, Madhu Kollareddy, et al.. (2024). Identifying targetable metabolic dependencies across colorectal cancer progression. Molecular Metabolism. 90. 102037–102037. 5 indexed citations
3.
Najumudeen, Arafath K., T J Collard, Hao Li, et al.. (2023). Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition. SHILAP Revista de lepidopterología. 11(1). 18–18. 5 indexed citations
4.
Jiménez-Moreno, Natalia, Madhu Kollareddy, Zuriñe Antón, et al.. (2023). ATG8-dependent LMX1B-autophagy crosstalk shapes human midbrain dopaminergic neuronal resilience. The Journal of Cell Biology. 222(5). 9 indexed citations
6.
Szemes, Marianna, Zsombor Melegh, Alexander Greenhough, et al.. (2020). A Wnt-BMP4 Signaling Axis Induces MSX and NOTCH Proteins and Promotes Growth Suppression and Differentiation in Neuroblastoma. Cells. 9(3). 783–783. 6 indexed citations
7.
Szemes, Marianna, Zsombor Melegh, Anthony R. Dallosso, et al.. (2020). Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against MYCN-Amplified Neuroblastoma. Frontiers in Oncology. 10. 818–818. 15 indexed citations
8.
Szemes, Marianna, Alexander Greenhough, Zsombor Melegh, et al.. (2018). Wnt Signalling Drives Context-Dependent Differentiation or Proliferation in Neuroblastoma. Neoplasia. 20(4). 335–350. 31 indexed citations
9.
Kollareddy, Madhu, Alice Sherrard, Ji Hyun Park, et al.. (2017). The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis. Cancer Letters. 403. 74–85. 27 indexed citations
10.
Carrero, Zunamys I., Madhu Kollareddy, Krishna M. Chauhan, Gopalakrishnan Ramakrishnan, & Luis A. Martinez. (2016). Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation. Oncotarget. 7(11). 12554–12567. 14 indexed citations
11.
Martinez, Luis A. & Madhu Kollareddy. (2015). Abstract 2108: Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities. Cancer Research. 75(15_Supplement). 2108–2108. 1 indexed citations
12.
Kollareddy, Madhu, Krishna C. Vallabhaneni, Adriano Chan, et al.. (2015). Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities. Nature Communications. 6(1). 7389–7389. 96 indexed citations
13.
Chauhan, Krishna M., Gopalakrishnan Ramakrishnan, Madhu Kollareddy, & Luis A. Martinez. (2015). Characterization of cancer-associated missense mutations in MDM2. Molecular & Cellular Oncology. 3(2). e1125986–e1125986. 6 indexed citations
14.
Kollareddy, Madhu, Daniella Zheleva, Petr Džubák, et al.. (2012). Aurora kinase inhibitors: Progress towards the clinic. Investigational New Drugs. 30(6). 2411–2432. 191 indexed citations
15.
Kollareddy, Madhu, et al.. (2012). Cancer Cell Resistance to Aurora Kinase Inhibitors: Identification of Novel Targets for Cancer Therapy. Journal of Proteome Research. 12(1). 455–469. 20 indexed citations
16.
Brulíková, Lucie, Petr Džubák, Marián Hajdúch, et al.. (2010). Synthesis of 5-[alkoxy-(4-nitro-phenyl)-methyl]-uridines and study of their cytotoxic activity. European Journal of Medicinal Chemistry. 45(9). 3588–3594. 7 indexed citations
17.
Kollareddy, Madhu, Petr Džubák, Daniella Zheleva, & Marián Hajdúch. (2008). AURORA KINASES: STRUCTURE, FUNCTIONS AND THEIR ASSOCIATION WITH CANCER. Biomedical Papers. 152(1). 27–33. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026